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Summary
Objective: Calciﬁcation of hypertrophic chondrocytes is the ﬁnal step in the differentiation of growth plates, although the precise mechanism is
not known. We have established two growth plate-derived chondrocyte cell lines, MMR14 and MMR17, from p53/ mice (Nakamata T,
Aoyama T, Okamoto T, Hosaka T, Nishijo K, Nakayama T, et al. In vitro demonstration of cell-to-cell interaction in growth plate cartilage using
chondrocytes established from p53/ mice. J Bone Miner Res 2003;18:97e107). Prolonged in vitro culture produced calciﬁed nodules in
MMR14, but not in MMR17. Factors responsible for the difference in calciﬁcation between the two cell lines may also be involved in the phys-
iological calciﬁcation in growth plate.
Design: Gene expression proﬁles of MMR14 and MMR17 were compared using a cDNA microarray to identify candidate genes involved in the
calciﬁcation process.
Results: Forty-ﬁve genes were identiﬁed as upregulated in MMR14, including the cadherin-11 (Cdh-11) gene. The expression of Cdh-11 in
MMR14 was detected in cellecell junctions, while no expression was observed in MMR17. Primary cultured chondrocytes from growth plate
(GC) also expressed the Cdh-11, and the staining of Cdh-11 was observed in the late hypertrophic zone of growth plate. Cell aggregation
assays showed that chondrocytes required Ca2þ to form nodules, and knockdown of the Cdh-11 gene expression using short interfering
RNA inhibited the formation of calciﬁed nodules in MMR14. The introduction of Cdh-11 into MMR17 failed to produce calciﬁed nodules indi-
cating that Cdh-11 is one, but not the sole, factor responsible for the production of calciﬁed nodules.
Conclusion: Although the physiological role is still unclear, Cdh-11 is a discriminative factor between articular and growth plate chondrocytes.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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The formation of bone tissues occurs via either a direct
(intramembranous) or an indirect (endochondral) process1,
the latter involving exploitation of the unique properties of
cartilage and bone. The growth plate cartilage, which is
a layered cartilage tissue separating the epiphysis and
metaphysis in growing tubular bones, provides a site for
physiological endochondral bone formation. Chondrocytes
in growth plates undergo proliferation, maturation, hypertro-
phy, and calciﬁcation associated with programmed cell
death, and ﬁnally are replaced by bone cells. A number of
molecules are involved in the development, behavior, and
function of growth plate chondrocytes, including, signaling
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tors10e12. It is, however, not yet known how the transit of
cells from one zone to the next is regulated. One feasible
approach may be to compare gene expression proﬁles be-
tween cells in different zones. Using a combination of laser
captured technology and a cDNA microarray, Wang et al.
compared in vivo gene expression proﬁles between chon-
drocytes in the proliferating and hypertrophic zone in the
growth plate of rat tibiae13. The genes for matrix metallopro-
teinase (Mmp) 13, alpha 1(X) collagen (Col1a1), ﬁbroblast
growth factor receptor 1 (Fgfr1), transforming growth factor
beta 1-induced transcript and members of the bone mor-
phogenetic protein (Bmp) family were identiﬁed as upregu-
lated in hypertrophic chondrocytes13. Conﬁrmation of the
role of these gene products may require cell lines, derived
from each zone, which are extremely difﬁcult to establish
from normal animals.
Cells isolated fromp53/mice are prone to be spontane-
ously immortalized without losing their differentiated pheno-
type, and we have established an osteoblast cell line from
calvaria14, and chondrocyte cell lines from articular carti-
lage15 and growth plate cartilage16. Three cell lines,
MMR32, MMR14 and MMR17, were established from costal
growth plates of p53/mice16. Expression proﬁles of carti-
lage-related molecules of MMR14 and MMR17 suggested353
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trophic zone, and a prolonged culture increased the expres-
sion of calciﬁcation-related genes in both cell lines16. An
intriguing difference between these two cell lines is their abil-
ity to produce nodules; under standard culture conditions
without stimuli speciﬁc for calciﬁcation, MMR14 produced
multiple nodules with signs of calciﬁcation, whereas
MMR17 formed no nodules and therefore exhibited no signs
of calciﬁcation16. Factors responsible for the difference in cal-
ciﬁcation between the two cell lines may also be involved in
the physiological calciﬁcation of hypertrophic chondrocytes.
Here we have performed gene expression proﬁling to identify
MMR14- or MMR17-speciﬁc upregulated genes. Based on
the proﬁles, the cadherin-11 (Cdh-11: also called OB-cad-
herin) gene was identiﬁed as an MMR14-speciﬁc upregu-
lated gene, and further expression and functional analyses
suggested that theCdh-11 gene is one of the factors involved
in the process of calciﬁcation of growth plate chondrocytes.
Materials and methods
CELL CULTURE AND TISSUE SAMPLES
MMR14 and MMR17 were cultured in DMEM/Ham’s F12
(1:1) (Sigma Aldrich, St. Louis, MO) supplemented with
10% fetal bovine serum (FBS) (Hyclone, Road Logan,
UT) and antibiotics at 37(C in a humidiﬁed atmosphere of
5% CO2/95% air. Calciﬁed nodules were stained with aliza-
rin red as described previously16. Tissues were harvested
from 4-week-old C57BL/6J mice. Articular cartilage tissues
were resected from femora and tibiae, and bone tissues
were obtained from calvaria. Growth plate cartilages were
dissected from the proximal portion of the cartilage adjacent
to the bone tissue under a microscope. Each tissue was
properly processed for RNA and protein analyses. The tis-
sues were subsequently cut with scissors into small pieces
and dispersed with 0.1% collagenase (Nitta Gelatin, Osaka,
Japan). Isolated chondrocytes were cultured in DMEM/
Ham’s F12 supplemented with 10% FBS. Animal studies
were approved by the institutional animal research commit-
tee, and performed according to the Guidelines for Animal
Experiments of Kyoto University.
GENE EXPRESSION PROFILING
Gene expression proﬁles of MMR14 and MMR17 were
compared using a custom-made cDNA microarray, which
consisted of 964 mouse genes of a standard chip (Intelli-
Gene Mouse CHIP Ver. 1, TaKaRa Bio, Shiga, Japan)
and an additional 78 bone- and cartilage-related mouse
genes as described previously15. Both MMR14 and
MMR17 cells were cultured for 1 week. Total RNA (20 mg)
extracted from cells was labeled by Molony-murine leuke-
mia virus (M-MLV) reverse transcriptase (400 U) (TaKaRa
Bio) with ﬂuorescence-conjugated Cy3- or Cy5-dUTP
(Amersham Biosciences, Buckinghamshire, UK), respec-
tively. Equal amounts of Cy3- and Cy5-labeled cDNAs
were mixed in the reaction buffer (6 SSC with 0.2%
SDS, 5 Denhardt’s solution, and 0.1 mg/ml denatured
salmon sperm DNA), and hybridized to the cDNA chip at
65(C overnight. The chip was washed with 2 SSC with
0.2% SDS twice at 55(C for 5 min and then once at 65(C
for 5 min. Finally, the chip was washed with 0.05 SSC
at room temperature for 1 min. The hybridized signal was
visualized and quantiﬁed using the Affymetrix 418 Array
Scanner (Affymetrix, Santa Clara, CA) and ImaGene soft-
ware (BioDiscovery, Marina Del Rey, CA).REVERSE TRANSCRIPTION-POLYMERASE
CHAIN REACTION (RT-PCR)
Cells were seeded at a density of 3 105 cells per 100-
mm culture dish, and total RNA was extracted on days 2,
7 and 21 using Trizol Reagent (Invitrogen, Carlsbad, CA),
followed by treatment with DNase I (Nippon Gene, Tokyo,
Japan). All RT reactions were performed using 1 mg of total
RNA with a Super Script First Strand Synthesis System for
RT-PCR kit (Invitrogen) according to the manufacturer’s di-
rections. PCR ampliﬁcation was carried out using 1 ml of RT
product in a ﬁnal volume of 25 ml containing 20 pmol each of
the sense and antisense primers, 25 mM MgCl2, 0.2 mM of
each dNTP, and 1 U of rTaq polymerase (TOYOBO, Osaka,
Japan). All reactions were performed using GeneAmp 9700
(PE Applied Biosystem, Foster, CA). Sequences of primers
are listed in Table I. PCR products were separated in
a 1.5% agarose gel and stained with ethidium bromide.
The intensity of the ampliﬁed fragments of the Cdh-11
and beta-actin genes was evaluated using NIH image and
the ratio of Cdh-11 to beta-actin was calculated in each
case. PCR experiments for each gene were performed at
least three times to conﬁrm the consistency of results. Cul-
ture experiments were done at least twice, and the RNA ex-
tracted from cells in each experiment was analyzed
separately. Tissues from each portion were processed for
the isolation of RNA using Trizol Reagent.
WESTERN BLOTTING
Whole cell lysates were prepared from MMR14 cells,
MMR17 cells and primary cultured chondrocytes, separated
by SDS-PAGE using 10% polyacrylamide gel, and trans-
ferred to a nitrocellulose membrane (Millipore, Bedford,
MA). The membrane was treated with speciﬁc antibodies
for Cdh-11 (Zymed Lab, San Francisco, CA) at a dilution
of 1:1000 and then with goat anti-rabbit IgG antibody conju-
gated to horseradish peroxidase as a secondary antibody
(Dako, Glostrup, Denmark), and ﬁnally visualized using an
ECL plus kit (Amersham Biosciences, Buckinghamshire,
UK).
IMMUNOHISTOCHEMISTRY
Knee joints were dissected from 4-week-old mice, ﬁxed
overnight at 4(C in periodateelysineeparaformaldehyde
solution, and then embedded in parafﬁn. Longitudinal serial
sections were cut at 6 mm, and the immunostaining was per-
formed using the DAKO Envision plus System (Dako). De-
parafﬁnized sections were treated with hydrogen peroxide
for 10 min to reduce endogenous peroxidase activity and
washed in Tris-buffered saline (TBS). Sections were treated
with anti-Cdh-11 antibody at a dilution of 1:100, and further
incubated overnight at 4(C. Nonimmune rabbit IgG (Dako)
was used as a negative control. Stained slides were coun-
terstained with hematoxylin, dehydrated in ethanol, cleared
in xylene, and mounted in Entellan (MERCK, Darmstadt,
Germany).
IMMUNOCYTOCHEMISTRY
MMR14 cells, MMR17 cells and primary cultured growth
plate chondrocytes were seeded at a density of
1 103 cells per well of a Lab-Tek II chamber slide system
(Nalgen Nunc Int. Corp., Rochester, NY). After 7 days of
culture, cells were rinsed twice with phosphate-buffered sa-
line (PBS), ﬁxed with 4% paraformaldehyde/PBS for 15 min
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Information of primers used in the RT-PCR analyses
Gene Primers Size (bp) Position Accession no.
Cdh-1 (E-cadherin) ACGTATCAGGGTCAAGTGCC 376 1268e1287 NM_009864
CCTGACCCACACCAAAGTCT 1624e1643
Cdh-2 (N-cadherin) CAAGAGCTTGTCAGAATCAGG 363 864e884 M31131
CATTTGGATCATCCGCATC 1209e1227
Cdh-3 (P-cadherin) GAGTTTGAGCCGCAGAAGTA 340 1000e1019 X06340
AACACAGGGGCTTCGTTGAC 1321e1340
Cdh-4 (R-cadherin) AAACAGGGGACATCGTGACC 396 1052e1071 D14888
AAGGCACGGTTCAGCTCATA 1428e1448
Cdh-5 (VE-cadherin) TCCGATACGAATACCTGAGC 543 1113e1132 D63942
TTGCTGTCCTCGTTCTTCAG 1637e1656
Cdh-6 (K-cadherin) TTCAAAGACTCGGCCACGGT 335 1090e1119 D82029
TAGAGGAACGCGGCTGCTTTG 1402e1422
Cdh-8 ACTCTGGTGGTCTGTCTGGA 601 985e1004 X95600
AGTTGCCAGTGTTATCTTCC 1567e1586
Cdh-11 (OB-cadherin) TCTGTATCAGAAGCAGCTGTC 729 1095e1115 D21253
TCCTGGTCATCTGCACTAAC 1806e1825
Cdh-15 (M-cadherin) CCCTGGACTATGAGAGCCGT 645 1498e1517 M74541
GCATGGCTCACGTTAATCTG 2124e2143
Col2a1 CACACTGGTAAGTGGGGCAAGACCG 173 31276e31300 M65161
GGATTGTGTTGTTTCAGGGTTCGGG 31448e31424
Col10a1 ATGCCGCTTGTCAGTGCTA 625 6670e6688 X67348
GATCCTCACATACCCACTG 7294e7276
Aggrecan GTCCCTGGTCAGCCCCACTTG 636 1561e1581 NM_007424
CACTGACACACCTCGGAAGCA 2176e2196
Pthrpr TGCTTGCCACTAAGCTTCG 214 1207e1225 X78936
TCCTAATCTCTGCCTGCACC 1451e1470
Alkaline phosphatase GCCCTCTCCAAGACATATA 363 478e486 J02980
CCATGATCACGTCGATATCC 821e840
Osteoblastic speciﬁc
factor 2 (Osf2)
ATGCTTCATTCGCCTCACAAAC 655 1e22 AF010284
CTACAACCTTGAAGGCCACG 636e655
Osteocalcin TCTGACAAAGCCTTCATGTC 199 136e155 X04142
AAATAGTGATACCGTAGATGCG 313e334
Bsp1/Opn ACACTTTCACTCCAATCGTCC 240 608e628 X16151
TGCCCTTTCCGTTGTTGTCC 828e847
Bsp2 TCGAAGAATCAAAGCAGAGGA 156 151e171 NM_008318
CTATCGCAGTCTCCATTTTC 287e306
Osterix TTGAGGAAGAAGCTCACTATGGC 390 119e139 AF184902
TGTACCACGAGCCATAGGGATG 487e508
b actin AAGAGAGGTATCCTGACCCT 218 261e280 X03672
TACATGGCTGGGGTGTTGAA 458e478
All primer sequences are written from 5# to 3#. For each primer pair, the top sequence is sense and the bottom is antisense.at room temperature, and rinsed three times with TBS. The
samples were treated with hydrogen peroxide for 10 min to
reduce endogenous peroxidase activity and washed in
TBS. Samples were treated with anti-Cdh-11 antibody at
a dilution of 1:500, and further incubated overnight at
4(C. Nonimmune rabbit IgG was used as a negative con-
trol. After three washes in TBS, samples were treated with
a 1:100 dilution of ﬂuorescent-conjugated anti-rabbit anti-
body at 37(C for an hour. Stained slides were washed
with TBS, counterstained with DAPI, mounted with cover
slips, and observed with a confocal laser scanning
microscope.
CELL AGGREGATION ASSAY
The cell aggregation assay was performed using the orig-
inal method17. After 2 weeks in culture, monolayer cells
were dissociated with 0.01% trypsin in the presence (TC
treatment) or absence (TE treatment) of 1 mM CaCl2 for
30 min at 37(C. After being washed with HEPES-buffered
Ca2þ, Mg2þ-free Hanks’ solution (HCMF), the cells were al-
lowed to aggregate in HCMF with or without 1 mM CaCl2
and shaken for 60 min at 37(C.CONSTRUCTION OF RETROVIRAL VECTOR
AND ESTABLISHMENT OF STABLE CELL LINE
Full-length murine Cdh-11 cDNA kindly provided by Dr
Takeichi was subcloned into the pQCXIH retrovirus vector
(Invitrogen), and the recombinant virus (pQCXIH-Cdh11)
was transfected into Ampho293 cells by lipofection using
Lipofectoamine Plus (Invitrogen), and the culture superna-
tant was harvested at 48 h posttransfection. One milliliter
of ﬂuid was added to MMR17 cells in the presence of poly-
brene (6 mg/ml), and a stable cell line was obtained after 3
weeks of culture under drug selection.
CONSTRUCTION AND TRANSDUCTION OF LENTIVIRAL
VECTORS EXPRESSING SHORT INTERFERING RNA
The CMV promoter of pLenti6/V5-DEST (Invitrogen) was
removed by digestion of ClaI and AgeI, and the cut end
was blunted, into which the Gateway recipient cassette
rFA (Invitrogen) was inserted. Human U6 promoter was
transferred into SalI and NotI sites of pENTR1A (Invi-
trogen), and the short hairpin oligonucleotides were
Table II
Gene symbol Accession no.
Opn AF515708
Mglap NM_008597
Anxa5 NM_009673
Sdc2 NM_008304
Sepp1 NM_009155
Enpp2 NM_015744
Mfge8 NM_008594
Cd97 NM_011925
Cd151 NM_009842
Itgb1 NM_010578
Csf1 NM_007778
ScyA9 AF128195
Cﬂ2 BC007138
Nf2 NM_010898
Tgfbr2 BC016262
Camk2d NM_023813
Hras1 NM_008284
Dusp1 NM_013642
RhoC AK011599
Gng2 NM_010315
ity 1 Nbl1 NM_008675
Mlp NM_010807
Hrsp12 NM_008287
Ndrg1 NM_010884
Homer3 NM_011984
Got2 NM_010325
Aldoa NM_007438
Gaa NM_008064
IMPA1 AF042730
Pparg NM_011146
Hmga1 NM_016660
c-jun J04115
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Upregulated genes in MMR14 Gene symbol Accession no. Upregulated genes in MMR17
Extracellular cell matrix Procollagen, type I, alpha 1 Col1a1 BC050014 Osteopontin
Procollagen, type XI, alpha 1 Col11a1 NM_007729 Matrix gamma-carboxyglutamate
(gla) protein
Fibronectin 1 Fn1 NM_010233 Annexin A5
Fibulin-1 Fbln1 NM_010180 Syndecan 2
Tenascin C Tnc NM_011607 Selenoprotein P, plasma, 1
Laminin, gamma 1 Lamc1 NM_010683
Thrombomodulin Thbd NM_009378
ECM-related enzyme Alkaline phosphatase 2 Alp2 NM_007431 Ectonucleotide pyrophosphatase/
phosphodiesterase 2
Matrix metalloproteinase 13 Mmp13 NM_008607
Calpain 6 Capn6 NM_007603
Cell surface marker CD59 Cd59 U60473 Milk fat globule-EGF factor 8 protein
Neogenin Neo1 NM_008684 CD97
Cadherin-11 Cdh-11 NM_009866 CD151
Immunoglobulin superfamily
containing leucine-rich repeat
Islr NM_012043 Integrin beta 1
Colony stimulating factor 1 (macrophage)
Small inducible cytokine A9
Cytoskeleton-related Myosin IB Myo1b NM_010863 Coﬁlin 2
Neural precursor cell expressed
developmentally downregulated
gene 5
Nedd5 D49382 Neuroﬁbromatosis 2
KAP3B Kap3 D50367
Signal molecule Parathyroid hormone/parathyroid
hormone related peptide receptor
Pthrpr X78936 Transforming growth factor, beta receptor II
Fibroblast growth factor receptor 1 Fgfr1 NM_010206 Calcium/calmodulin-dependent protein
kinase II, delta
Transforming growth factor beta 1
induced transcript 1
Tgfb1i1 NM_009365 Harvey rat sarcoma virus oncogene 1
MAD homolog 3 Smad5 NM_016769 Dual speciﬁcity phosphatase 1
Bone morphogenetic protein 4 Bmp4 NM_007554 RhoC
U28423 G protein, gamma 2 subunit
Neuroblastoma, suppression of tumorigenic
MARCKS-like protein
Heat-responsive protein 12
Cytoplasmic protein Phosphoprotein enriched in
astrocytes 15
Pea15 NM_011063 N-myc downstream regulated gene 1
Protein kinase inhibitor p58 Prkrir NM_028410 Homer homolog 3
Metabolic enzyme Ornithine decarboxylase, structural 1 Odc1 NM_013614 Glutamate oxaloacetate transaminase 2
Methylenetetrahydrofolate
dehydrogenase (NADþ dependent)
Mthfd2 NM_008638 Aldolase 1, A isoform
Glucosidase, alpha, acid
Lithium-sensitive myo-inositol
monophosphatase A1
Transcription factor SRY-box containing gene 9 Sox9 NM_011448 Peroxisome proliferator activated
receptor gamma
High mobility group AT-hook 1
c-jun protein oncogene
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d inserted at the 3# site of the U6 promoter. The sequences of
the short hairpin oligonucleotides for Cdh-11 are sense 5#-
GCCCCAAGTTATATCCATGAGGAAGCTTGGTCATGGA
TATAACTTGGGGCTTTTTGC-3# and the antisense 5#-
GGCCGCAAAAAGCCCCAAGTTATATCCATGACCAAGC
TTCCTCATGGATATAACTTGGGGC-3#. As a negative con-
trol, short hairpin oligonucleotides for the ﬁreﬂy luciferase
gene were used. The sense sequence was 5#-TCGATGTA
CACGTTCGTCACGAAGCTTAGTGACGAACGTGTACAT
CGACTTTTTGC, and the antisense sequence was 5#-
GGCCGCAAAAAGTCGATGTACACGTTCGTCACTAAGC
TTCGTGACGAACGTGTACATCGA. Then the Gateway
Technology recombined the entry vector with the lentiviral
vector. The lentiviral siRNAvector forCdh-11wasdesignated
LV-Cdh11i and the lentiviral siRNA vector for luciferase was
designated LV-FFi. Lentiviral supernatants were produced
according to the manufacturer’s directions (Invitrogen). For
transduction, 1 105 MMR14 cells were seeded per well of
a 6-well plate and infected after 24 h.MMR14 cells were incu-
bated with 1 ml of unconcentrated virus containing 4 mg/ml of
polybrene. Transduced cells were cultured in DMEM/Ham’s
F12 with 10% FBS for 21 days. For cloning, the transduced
cells were treated with 2 mg/ml of blasticidin. After 2 weeks
of culture, antibiotic-resistant colonies were removed and
expanded for assay. Calciﬁed nodules were stained with
alizarin red. The number of calciﬁed nodules was manually
enumerated under a microscope, and the calciﬁed area
was analyzed with NIH image.
STATISTICS
Results are expressed as the mean S.E. Statistical
analysis was performed with Student’s t test. A signiﬁcant
difference was accepted at the P< 0.05 level. Each exper-
imental group was compared with its own control, which
was prepared and analyzed simultaneously.
Results
IDENTIFICATION OF GENES DIFFERENTIALLY EXPRESSED
BETWEEN MMR14 AND MMR17
Genes differentially expressed between MMR14 and
MMR17 were identiﬁed using the cDNA microarray. Forty-
ﬁve genes were identiﬁed as upregulated in MMR14, their
expression being more than twofold that in MMR17
(Table II). Among 45 upregulated genes, 12 were ex-
pressed sequence tags (ESTs), and 33 were known genes,
some of which have been shown to promote calciﬁcation or
aggregation in growth plates, such as the SRY-box contain-
ing gene 9 (Sox9), Col1a1, alkaline phosphatase (Alp),
Bmp4 and Mmp13 genes. Using equivalent criteria, 48
genes were identiﬁed as in MMR17 cells, their expression
being more than twofold that in MMR14 (Table II). Among
them, six were ESTs and 42 were known genes, some of
which have been shown to prevent calciﬁcation or aggrega-
tion, such as the matrix gamma-carboxyglutamate (gla) pro-
tein (Mglap), CD151 and ectonucleotide pyrophosphatase/
phosphodiesterase 2 (Enpp2) genes.
Among MMR14-speciﬁc upregulated genes is the gene
for Cdh-11, which has been recognized as an osteoblast-
speciﬁc cadherin18, and shown to regulate the cellecell
adhesion and nodular formation of osteoblasts, which is
important for mineralization of the osteoid matrix19,20.
The role of cartilage tissues, however, was never
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this study.
CONFIRMATION OF THE RESULTS OBTAINED
WITH THE cDNA MICOARRAY
To conﬁrm the results obtained with the cDNA microar-
ray, mRNA expression of the Cdh-11 gene in MMR14 and
MMR17 was analyzed by semiquantitative RT-PCR. The
expression of the Cdh-11 gene increased in a time-depen-
dent manner in MMR14 cells, but was not detected in
MMR17 cells at any of the time points [Fig. 1(A)]. The level
of Cdh-11 protein expression was well correlated with the
level of mRNA expression [Fig. 1(B)], and the immunocyto-
chemical analysis clearly showed that Cdh-11 was
expressed in areas of cellecell junctions in MMR14 after
1 week of culture, but was not observed in MMR17
[Fig. 1(D)]. These results conﬁrmed the result of the gene
expression proﬁling.Cdh-11 IS EXPRESSED IN NORMAL CHONDROCYTES
DERIVED FROM GROWTH PLATE CARTILAGE
To investigate whether Cdh-11 is expressed in normal
chondrocytes in growth plates, primary cultured chondro-
cytes from costal growth plates (GC) were analyzed as
well as primary cultured chondrocytes from articular carti-
lage (AC) and primary cultured osteoblasts from calvaria
(CO). The expression of the Cdh-11 gene was also de-
tected in CO as well as in GC, but not in AC [Fig. 2(A), cen-
ter panel]. Expression of the Col10a1 and parathyroid
hormone related peptide receptor (Pthrpr) genes, which
were considered as markers of growth plates, was detected
only in GC and not in AC or CO [Fig. 2(A), left panel]. On the
other hand, the expression of osteocalcin, osteopontin
(Opn), and bone sialoprotein 2 (Bsp2) genes, which were
considered as markers of osteoblasts, was not detected
in GC [Fig. 2(A), right panel], suggesting that the contami-
nation of osteoblasts in GC was minimal. The level of
Cdh-11 protein expression was upregulated during cultureFig. 1. Expression of Cdh-11 in MMR14 and MMR17. The expression of Cdh-11 in MMR14 and MMR17 cells during culture was examined by
RT-PCR (A) and Western blotting (B). Localization of Cdh-11 was analyzed by immunocytochemistry (C). Counterstained with DAPI (original
magniﬁcation, 400; bar¼ 10 mM).
359Osteoarthritis and Cartilage Vol. 14, No. 4Fig. 2. Expression of Cdh-11 in primary cultured articular chondrocytes, growth plate chondrocytes and COs. The mRNA expression of Cdh-11
and bone/cartilage-related genes in primary cultured articular chondrocytes, growth plate chondrocytes and COs was examined by RT-PCR
(A). The expression of Cdh-11 protein in these primary cultured cells was analyzed by Western blotting (B) and immunocytochemistry (C).
Counterstained with DAPI (original magniﬁcation, 400; bar¼ 10 mM).in GC as well as in CO [Fig. 2(B)], and immunocytochemical
analysis showed that Cdh-11 protein was properly ex-
pressed in areas of cellecell junctions in GC and CO, but
not in AC [Fig. 2(C)].
Cdh-11 IS EXPRESSED IN VIVO IN GROWTH PLATE
CARTILAGE
Localization of Cdh-11-positive cells in growth plate was
investigated by the immunohistochemical analysis. Positive
staining for Cdh-11 protein was observed in cells from the
late hypertrophic zone to calciﬁed zone of mouse growth
plate cartilage (Fig. 3).
EXPRESSION OF THE CADHERIN GENE FAMILY
IN CHONDROCYTES
Cadherin genes compose a large family, and some may
be functionally redundant21,22. The expression of some
classical cadherin genes was analyzed by RT-PCR in cell
lines and primary cultured cells (Fig. 4). The cadherin-2(Cdh-2, N-cadherin) and cadherin-3 (Cdh-3, P-cadherin)
genes were expressed in cell lines (MMR14 and MMR17)
(Fig. 4, left panel), and also in primary cultured cells (AC,
GC, and CO) (Fig. 4, right panel). The cadherin-5 (Cdh-5,
VE-cadherin) was negative in cell lines, whereas it was de-
tected in primary cultured GC and CO, presumably due to
contaminated endothelial cells in primary cultured cells.
Therefore, among the classical cadherin genes analyzed,
only the Cdh-11 gene showed a difference between
MMR14 and MMR17, which also showed a difference be-
tween AC and GC.
CELLeCELL ADHESION OF MMR14 AND PRIMARY
CULTURED CHONDROCYTES REQUIRES CA2þ
To examine the dependence of MMR14 cells on Ca2þ for
cellecell adhesion, a cell aggregation assay was per-
formed. At day 14 of culture, MMR14 cells produced a num-
ber of nodules. When trypsinization was carried out with
CaCl2 (TC treatment), cells in nodules were resistant to dis-
sociation ([Fig. 5(A, a)], whereas the trypsinization without
360 T. Matsusaki et al.: Cadherin-11 in growth plate chondrocyteFig. 3. Expression of Cdh-11 in growth plate. Localization of Cdh-11 in growth plate was analyzed by immunohistochemistry. Decalciﬁed
specimens were stained with antibody for Cdh-11 (A) or nonimmune IgG (B). Same specimens were also stained with Safranin-O (C).
Each specimen was counterstained with hematoxylin (original magniﬁcation, 400; bar¼ 50 mM).CaCl2 (TE treatment) dispersed the nodules [Fig. 5(A, b)].
The number of alizarin red-positive nodules after TC treat-
ment [Fig. 5(B, a)] was much higher than that after TE treat-
ment [Fig. 5(B, b)], and the difference was statistically
signiﬁcant [Fig. 5(C)]. These results suggested that
Fig. 4. Expression of cadherin family genes. The expression of cad-
herin family genes in cell lines and primary cultured articular chon-
drocytes, growth plate chondrocytes and COs was examined by
RT-PCR.MMR14 cells required Ca2þ to maintain the nodular
aggregation.
After being dispersed by trypsinization without CaCl2 (TE
treatment), cells were allowed to reaggregate in HCMF with
[Fig. 5(D, a, c, and e)] or without [Fig. 4(D, b, d, and f )]
CaCl2. MMR17 cells showed no aggregation irrespective
of the presence of CaCl2 [Fig. 5(D, a and b)]. On the other
hand, MMR14 cells attached to each other in the presence
[Fig. 5(D, c)] but not absence [Fig. 5(D, d )] of CaCl2. Similar
results were obtained with primary cultured GCs, which
showed aggregation when incubated with [Fig. 5(D, e)]
but not without [Fig. 5(D, f )] CaCl2. These results indicated
that the cellecell adhesion of MMR14 and primary cultured
chondrocytes depends on factors requiring Ca2þ, suggest-
ing the involvement of cadherins, and the signiﬁcant differ-
ence between MMR14 and MMR17 cells strongly
suggested that Cdh-11 is the cadherin gene responsible
for this phenomenon.
SUPPRESSION OF CDH-11 GENE EXPRESSION INHIBITED
THE FORMATION OF NODULES BY MMR14 CELLS
To further investigate the role of Cdh-11 in the formation
of nodules by MMR14 cells, the expression of the gene was
suppressed by siRNA. Three weeks after the transduction
of the lentiviral vector expressing siRNA for the Cdh-11
gene (LV-Cdh11i) or ﬁreﬂy luciferase gene (LV-FFi), the
expression of the Cdh-11 gene was analyzed by RT-PCR.
LV-Cdh11i-transduced MMR14 cells (MMR14/LV-Cdh11i)
expressed much less of the Cdh-11 gene than parental
MMR14 cells or LV-FFi-transduced MMR14 cells
(MMR14/LV-FFi) [Fig. 6(A)]. The expression level of Alp
Fig. 5. Cellecell adhesion of MMR14 requires Ca2þ. MMR14 cells were cultured for 2 weeks to form nodules, and then treated with 0.01%
trypsin with (TC treatment) (A, a and B, a) or without (TE treatment) (A, b and B, b) 1 mM CaCl2. (A, a and b) Phase contrast view of nodules.
(B, a and b) Alizarin red staining of nodules. (C) The number of alizarin red-positive nodules after TC or TE treatment. Experiments were per-
formed individually two times. *P< 0.01. MMR17 cells (D, a and b), MMR14 cells (D, c and d ), and primary cultured chondrocytes from growth
plate (D, e and f ), were dispersed with 0.01% trypsin without CaCl2. After a wash with HCMF, cells were allowed to aggregate in HCMF with
(D, a, c, and e), or without (D, b, d, and f ) 1 mM CaCl2 (original magniﬁcation, 100).
362 T. Matsusaki et al.: Cadherin-11 in growth plate chondrocyteFig. 6. Knockdown of the expression of Cdh-11 by siRNA reduced the nodular formation of MMR14. The mRNA expression of the Cdh-11,
Cdh-2, Cdh-3 and Alp genes was analyzed by RT-PCR in MMR14, MMR14 transduced with lentiviral expression vectors containing siRNA
for the ﬁreﬂy luciferase gene (MMR14/LV-FFi), or the murine cadherin-11 gene (MMR14/LV-Cdh11i) (A). Calciﬁed nodules produced by
each cell were stained with alizarin red (B) and the number (C) and percent area (D) of alizarin red-positive nodules were calculated.
*P< 0.01, *P< 0.01.was also signiﬁcantly reduced in MMR14/LV-Cdh11i
[Fig. 6(A)]. The expression level of the Cdh-2 and Cdh-3
genes showed no difference between MMR14, MMR14/
LV-Cdh11i, and MMR14/LV-FFi, indicating speciﬁc sup-
pression of the Cdh-11 gene by LV-Cdh11i [Fig. 6(A)].
MMR14/LV-Cdh11i produced a fewer nodules than
MMR14 or MMR14/LV-FFi [Fig. 6(B)], and the statistical
analyses indicated that the number and percent area of cal-
ciﬁed nodules in MMR14/LV-Cdh11i were signiﬁcantly re-
duced [Fig. 6(C and D)]. To conﬁrm the association of
Cdh-11 expression with the ability to form nodules, several
stable clones were isolated, and the downregulation of the
Cdh-11 gene in each clone was analyzed and quantiﬁed
[Fig. 7(A)]. The number of calciﬁed nodules produced by
each clone was well correlated with the expression level
of the Cdh-11 gene in each clone [Fig. 7(A and B)]. These
data strongly suggested that the expression of the Cdh-11
gene is required for nodules to form in MMR14.INDUCTION OF Cdh-11 FAILED TO INDUCE THE FORMATION
OF NODULES BY MMR17 CELLS
To investigate whether Cdh-11 is capable of inducing the
formation of nodules in MMR17, the expression of its gene
was induced using the retroviral expression vector contain-
ing the full-length cDNA of the murine Cdh-11 gene
(pQCXIH-Cdh11). After 3 weeks of culture, the expression
of Cdh-11 RNA [Fig. 8(A)] and protein [Fig. 8(B)] was de-
tected in MMR17 cells transduced with pQCXIH-Cdh11
(MMR17/pQCXIH-Cdh11). The expression level of the Alp
gene in MMR17/pQCXIH-Cdh11 was slightly increased,
but other bone-related genes showed no signiﬁcant change
[Fig. 8(A)]. Expression of the Cdh-11 protein at cellecell
junctions in MMR17/pQCXIH-Cdh11 was conﬁrmed by im-
munocytochemistry [Fig. 8(C)]. The formation of nodules,
however, was not observed in MMR17/pQCXIH-Cdh11 or
in the control (MMR17/pQCXIH) [Fig. 8(D)]. These results
363Osteoarthritis and Cartilage Vol. 14, No. 4Fig. 7. Association of expression level of the Cdh-11 gene with the number of calciﬁed nodules in siRNA-transduced clones. MMR14 cells
transduced with LV-Cdh11i were cultured under drug selection, and single cell cloning by the limited dilution method was performed. Four
clones were randomly selected and further analyzed. The mRNA expression of the Cdh-11 gene of each clone was analyzed by RT-PCR
(A, upper), and the relative expression level was digitalized as described in the Materials and methods section (A, lower). Each clone was
cultured for 2 weeks to produce nodules, which were then stained with alizarin red (B, upper). The number and percent area of alizarin
red-positive nodules were calculated (B, lower).suggested that Cdh-11 is indispensable, but not the sole
factor, to induce nodular formation.
Discussion
Geneexpressionproﬁling ofMMR14andMMR17provided
a list of interesting genes. Among the genes upregulated in
MMR14 cells, some have been known to promote calciﬁca-
tion in the growth plate. Mmp13 is a member of the Mmp
family of neutral endopeptidases, and Mmp13 null mice
showed profound defects in growth plate cartilage23,24.
Alp is expressed from the hypertrophic zone to calcifying
zone in growth plate cartilage25, and osteoblasts in Alp
null mice differentiate normally but are unable to initiate min-
eralization in vitro26. Several extracellular matrix (ECM)
genes were also identiﬁed as upregulated in MMR14.
Col1a1 is a well known marker for osteogenesis, and
Col11a1 is so essential for the normal formation of cartilage
collagen ﬁbrils that mice, which are homozygous for the au-
tosomal recessive chondrodysplasia mutation, die at birth
with abnormalities in the cartilage of limbs, ribs, mandible,
and trachea27. Fibronectin is also expressed in the hyper-
trophic zone25. Fibulin-1 is a Ca2þ-binding ECM protein as-
sociated with ﬁbronectin, aggrecan and versican28,29, and
expressed in the hypertrophic zone of growth plates29, al-
though its precise function in the growth plate is unknown.
On the other hand, some genes upregulated in MMR17
cells are known to prevent calciﬁcation. Virally driven over-
expression of the Mgp gene in cultured chondrocytes de-
creased mineralization30. Mice deﬁcient in Mgp showed
calciﬁcation of the arteries31, and mice deﬁcient in both
Mgp and Opn had twice as much arterial calciﬁcation as
Mgp (/) Opn (þ/þ) mice, suggesting that Mgp and Opn
inhibit the calciﬁcation in vitro and in vivo31. The relation be-
tween Enpp2 and calciﬁcation is unclear, but a closely-relat-
ed gene, Enpp1, regulates ectopic ossiﬁcation32e34. CD151
is a member of the tetraspanin superfamily, and plays
a key role in the regulation of integrin-mediated cellmigration35e37. The identiﬁcation of these genes, the pro-
posed functions of which agreed with the phenotype of
each cell line, endorsed the reliability of our gene expres-
sion proﬁling, and we focused on one gene, Cdh-11, be-
cause of an absence of data on its expression in cartilage
tissue.
Cadherins are integral membrane glycoproteins that pro-
vide strong intercellular adhesion via homophilic molecular
associations in a Ca2þ-dependent manner38,39. Cadherin
genes form a gene superfamily that consists of two large
subfamilies, classical and atypical cadherins, the former be-
ing further divided into type 1 and type 239. Cdh-11 is a type
2 classic cadherin isolated as an osteoblast-speciﬁc gene
by subtraction screening between osteoblasts and liver
cells18,39. Subsequent analyses revealed that Cdh-11 regu-
lates osteoblastic differentiation in cellecell adhesion and
formation of calciﬁed nodules19,20. Recently, it was pro-
posed that in addition to its function in the formation of ma-
trices, Cdh-11 may promote the process by which
undifferentiated mesenchymal cells turn into osteogenic-lin-
eage cells20,40. When C2C12 cells were forced to express
Cdh-11, they began to express osteogenic markers such
as Alp and Fgfr240. We observed that the expression of
the Alp gene was downregulated by siRNA for the Cdh-11
gene [Fig. 6(A)] and upregulated by forced expression of
the Cdh-11 gene [Fig. 8(A)], which may be consistent with
previous ﬁndings.
As far as we know, no study has precisely analyzed the
signiﬁcance of Cdh-11 in cartilage tissues and chondro-
cytes. The results of the cell aggregation assay and siRNA
experiments clearly indicated that the function of Cdh-11 is
indispensable for the formation of calciﬁed nodules. Cdh-11
knockout mice, however, showed only a slight reduction in
bone density and an almost normal development of the
limb19. Cdh-2 (N-cadherin) knockout mice also had nor-
mally developed limbs41. Functional redundancy of Cdh-
11 and Cdh-2 was proposed to explain the discrepancy
between in vivo and in vitro experiments19,41. In the present
364 T. Matsusaki et al.: Cadherin-11 in growth plate chondrocyteFig. 8. Introduction of Cdh-11 expression in MMR17. The mRNA expression of cadherin and calciﬁcation-related genes was analyzed by RT-
PCR in MMR17 transduced with a retroviral expression vector containing the murine Cdh-11 gene (MMR17/QCXIH-Cdh11) or an empty vector
(MMR17/QCXIH) (A). The expression of Cdh-11 protein in these cells was analyzed by Western blotting (B) and immunocytochemistry (C)
(original magniﬁcation, 400; bar¼ 10 mM). Calciﬁed nodule formation of these cells was analyzed by alizarin red staining (D).study, however, the formation of nodules in MMR14 was se-
verely inhibited by the downregulation of Cdh-11 by siRNA,
which induced no change in the Cdh-2 gene expression.
Forced expression of Cdh-11 in MMR17 failed to induce
nodular formation. Therefore, it is clear that molecule(s)
other than Cdh-11 and Cdh-2 are also involved in the pro-
cesses of nodular formation and calciﬁcation.
It is paradoxical that cadherin is a cellecell adhesion mol-
ecule, whereas chondrocytes in hypertrophic zone do not
form cellecell attachment. In contrast with the strong expres-
sion of Cdh-11 in primary cultured GCs (Fig. 2), only somecells in calciﬁed chondrocytes were positive for the Cdh-11
(Fig. 3), suggesting that the release from lacunaemay induce
the expression of the Cdh-11 gene in cells in the growth
plate. Such an induction was not a nonspeciﬁc phenomenon
in vitro, because it was not observed in articular chondro-
cytes (Fig. 2). Chondrocytes are classiﬁed as either perma-
nent or transient based on their potential for calciﬁcation,
and it is important to identify which molecules promote calci-
ﬁcation in transient chondrocytes (growth plate cartilage) or
prevent the calciﬁcation of permanent chondrocytes (articu-
lar cartilage)42,43. As shown in this study, chondrocytes
365Osteoarthritis and Cartilage Vol. 14, No. 4isolated from growth plate expressed the Cdh-11 gene,
whereas primary cultured chondrocytes from AC as well as
MMA2 cells, an immortalized articular chondrocyte cell
line15, showed no expression of the Cdh-11 gene even after
prolonged in vitro culture (data not shown). MMA2, but not
MMR14, expressed the C-1-1 gene15, which is a marker of
permanent chondrocytes43,44. These results suggested
that the ability to express the Cdh-11 gene is one of the fea-
tures of transient chondrocytes, and therefore molecules
controlling the expression of the Cdh-11 gene in chondro-
cytes may determine their fate. In relation to this issue, the
negative expression of the Cdh-11 gene in MMR17 is intrigu-
ing. We have no clear explanation for the difference in the
expression level of the Cdh-11 gene between MMR14 and
MMR17. Cells without a p53 gene are known to have genetic
instability, and MMR17 may have a defect in the Cdh-11
gene, although no gross rearrangement was found (data
not shown). Treatment with 5-azacytidine failed to induce
the expression of the Cdh-11 gene, excluding the possibility
of methylation-induced gene silencing (data not shown). Im-
munohistochemical analyses in growth plates showed that
only cells in the late hypertrophic and calciﬁed zones ex-
hibited positive staining of the Cdh-11 gene, and most cells
in the hypertrophic zone were negative. These results sug-
gested that although the two cell lines shared a similar
gene expression proﬁle as cells in the hypertrophic zone16,
they may represent cells in different stages of differentiation
in the hypertrophic zone, and that factor(s) promoting the dif-
ferentiation may decide the different properties of MMR14
and MMR17.
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